Tennessee Oncology enrolls more cancer patients in clinical trials than any other providers in Tennessee.
Clinical trials evaluate the effectiveness of new drugs or treatment strategies. They test the safety and effectiveness of new or modified cancer drugs, drug doses, or combination of drugs with other treatments such as surgery or radiation therapy. To improve cancer treatment requires that new and innovative therapies be continually evaluated. Clinical trials are especially important in oncology. With the absence of high cure rates, nearly all therapeutic approaches are developmental in nature.
Despite the importance of clinical trials in the advancement of cancer care, less than 5% of patients participate. A clinical trial is recommended as the first option of treatment by leading cancer organizations. It is your decision whether or not to participate and a lot of information is available to help you in making the best decision for your care.
Tennessee Oncology works closely with Sarah Cannon Research Institute (SCRI) to provide our patients access to a variety of clinical trials. You can learn more about SCRI by visiting the website via the link above or by discussing with your physician the option of a clinical trial for your treatment.